160 related articles for article (PubMed ID: 34294460)
1. HLA-DRB1*04 may predict the severity of disease in a group of Iranian COVID-19 patients.
Ebrahimi S; Ghasemi-Basir HR; Majzoobi MM; Rasouli-Saravani A; Hajilooi M; Solgi G
Hum Immunol; 2021 Oct; 82(10):719-725. PubMed ID: 34294460
[TBL] [Abstract][Full Text] [Related]
2. Association of HLA class II (-DRB1,-DQB1,-DPB1) alleles and haplotypes on susceptibility to aplastic anemia in northern Chinese Han.
Qi J; Wang TJ; Li HX; Wu D; Du D; Wu JH; Shang LX; Chen L; Wang MN; Wang XF
Hum Immunol; 2020 Dec; 81(12):685-691. PubMed ID: 32693929
[TBL] [Abstract][Full Text] [Related]
3. Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.
Samimi-Rad K; Sadeghi F; Amirzargar A; Eshraghian MR; Alavian SM; Rahimnia R
J Med Virol; 2015 Sep; 87(9):1565-72. PubMed ID: 25970464
[TBL] [Abstract][Full Text] [Related]
4. Relevance of autoantibody profile with HLA-DRB1 and -DQB1 alleles in a group of Iranian systemic lupus erythematosus patients.
Rasouli-Saravani A; Tahamoli-Roudsari A; Basiri Z; Babaei M; Fazaeli A; Roshanaei G; Hajilooi M; Solgi G
Immunol Lett; 2021 Sep; 237():11-16. PubMed ID: 34186156
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen class II (DRB1 and DQB1) alleles and haplotypes frequencies in patients with pemphigus vulgaris among the Serbian population.
Zivanovic D; Bojic S; Medenica L; Andric Z; Popadic D
HLA; 2016 May; 87(5):367-74. PubMed ID: 27072514
[TBL] [Abstract][Full Text] [Related]
6. The influence of the HLA-DRB1 and HLA-DQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis.
Kollaee A; Ghaffarpor M; Ghlichnia HA; Ghaffari SH; Zamani M
Int J Immunogenet; 2012 Oct; 39(5):414-22. PubMed ID: 22404765
[TBL] [Abstract][Full Text] [Related]
7. Distribution of HLA-DRB1 and HLA-DQB1 alleles in Lak population of Iran.
Varzi AM; Shahsavar F; Tarrahi MJ
Hum Immunol; 2016 Jul; 77(7):580-3. PubMed ID: 27189628
[TBL] [Abstract][Full Text] [Related]
8. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
[TBL] [Abstract][Full Text] [Related]
9. Clinical Relevance of HLA-DRB1 and -DQB1 Alleles in Iranian Systemic Lupus Erythematosus Patients.
Rasouli-Saravani A; Tahamoli-Roudsari A; Behzad M; Hajilooi M; Solgi G
Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):67-75. PubMed ID: 33639633
[TBL] [Abstract][Full Text] [Related]
10. Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience.
Littera R; Campagna M; Deidda S; Angioni G; Cipri S; Melis M; Firinu D; Santus S; Lai A; Porcella R; Lai S; Rassu S; Scioscia R; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Serra M; Ragatzu P; Carta MG; Del Giacco S; Restivo A; Deidda S; Orrù S; Palimodde A; Perra R; Orrù G; Conti M; Balestrieri C; Serra G; Onali S; Marongiu F; Perra A; Chessa L
Front Immunol; 2020; 11():605688. PubMed ID: 33343579
[TBL] [Abstract][Full Text] [Related]
11. Association between HLA-DRB1*0405, -DQB1*0401 and -DQA1*0303 alleles and lamotrigine-induced cutaneous adverse drug reactions. A pilot case-control study from Japan.
Ito A; Shimada H; Ishikawa K; Takeo N; Hatano Y; Katagiri K; Kohno K; Araki Y; Terao T; Kojima H; Terao C; Eshima N; Fujiwara S
J Affect Disord; 2015 Jul; 179():47-50. PubMed ID: 25845749
[TBL] [Abstract][Full Text] [Related]
12. HLA DRB1/DQB1 alleles and DRB1-DQB1 haplotypes and the risk of rheumatoid arthritis in Tunisians: a population-based case-control study.
Lagha A; Messadi A; Boussaidi S; Kochbati S; Tazeghdenti A; Ghazouani E; Almawi WY; Yacoubi-Loueslati B
HLA; 2016 Sep; 88(3):100-9. PubMed ID: 27580864
[TBL] [Abstract][Full Text] [Related]
13. Frequency distribution of HLA alleles and haplotypes in Uyghur women with advanced squamous cell cervical cancer and relation to HPV status and clinical outcome.
Alifu M; Fan P; Kuerban G; Yao X; Peng Y; Dong T; Wang R
Arch Gynecol Obstet; 2018 Mar; 297(3):757-766. PubMed ID: 29356954
[TBL] [Abstract][Full Text] [Related]
14. Association of HLA-DRB1 and -DQ Alleles and Haplotypes with Type 1 Diabetes in Jordanians.
Khdair SI; Jarrar W; Jarrar YB; Bataineh S; Al-Khaldi O
Endocr Metab Immune Disord Drug Targets; 2020; 20(6):895-902. PubMed ID: 31742498
[TBL] [Abstract][Full Text] [Related]
15. The influence of HLA genotype on the severity of COVID-19 infection.
Langton DJ; Bourke SC; Lie BA; Reiff G; Natu S; Darlay R; Burn J; Echevarria C
HLA; 2021 Jul; 98(1):14-22. PubMed ID: 33896121
[TBL] [Abstract][Full Text] [Related]
16. HLA class II susceptibility pattern for type 1 diabetes (T1D) in an Iranian population.
Kiani J; Hajilooi M; Furst D; Rezaei H; Shahryari-Hesami S; Kowsarifard S; Zamani A; Solgi G
Int J Immunogenet; 2015 Aug; 42(4):279-86. PubMed ID: 26088816
[TBL] [Abstract][Full Text] [Related]
17. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population.
Amirzargar A; Mytilineos J; Farjadian S; Doroudchi M; Scherer S; Opelz G; Ghaderi A
Hum Immunol; 2001 Nov; 62(11):1234-8. PubMed ID: 11704285
[TBL] [Abstract][Full Text] [Related]
19. HLA-DRB, -DQA, and DQB alleles and haplotypes in Iranian patients with diabetes mellitus type I.
Rabbani A; Abbasi F; Taghvaei M; Rabbani B; Moradi B; Shakiba Y; Rezaei N; Amirzargar A
Pediatr Diabetes; 2013 Aug; 14(5):366-71. PubMed ID: 22583516
[TBL] [Abstract][Full Text] [Related]
20. Diversity of extended HLA-DRB1 haplotypes in the Finnish population.
Wennerström A; Vlachopoulou E; Lahtela LE; Paakkanen R; Eronen KT; Seppänen M; Lokki ML
PLoS One; 2013; 8(11):e79690. PubMed ID: 24278156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
